UnitedHealth price target raised to $675 from $605 at Stephens

Stephens raised the firm’s price target on UnitedHealth (UNH) to $675 from $605 and keeps an Overweight rating on the shares after having updated estimates and provided a detailed review of the granular 2025 guidance metrics that were shared before the company’s investor conference was “beset by terrible tragedy” as UHC CEO Brian Thompson was murdered. The firm, which says the “managed care investment community is shocked and saddened by this development,” says it thought going in the event “would have provided the perfect opportunity to reflect on the incredible growth and success the company has experienced during the past quarter-century.”